Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists
暂无分享,去创建一个
S. Brunton | Jeremy J Pruzin | A. Sabharwal | J. Pruzin | S. Alford | C. Hamersky | G. Gopalakrishna | Jeremy J Pruzin
[1] Anonymous,et al. 2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[2] Sonia Santander Ballestín,et al. Vitamin Supplementation and Dementia: A Systematic Review , 2022, Nutrients.
[3] Tih-Shih Lee,et al. Cardiometabolic and Vascular Disease Factors and Mild Cognitive Impairment and Dementia , 2022, Gerontology.
[4] Mina Esmail Zadeh Nojoo Kambar,et al. Alzheimer's disease drug development pipeline: 2022 , 2022, Alzheimer's & dementia.
[5] Nannan Shi,et al. Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements , 2021, Frontiers in Neurology.
[6] J. Weuve,et al. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060) , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[7] M. Sabbagh,et al. Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 , 2021, The Journal of Prevention of Alzheimer's Disease.
[8] M. Sabbagh,et al. Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient Management , 2021, Frontiers in Neurology.
[9] Jorge Riquelme-Galindo,et al. Experience of People in Mild and Moderate Stages of Alzheimer’s Disease in Spain , 2020, Aquichan.
[10] J. Cummings,et al. Repurposed agents in the Alzheimer’s disease drug development pipeline , 2020, Alzheimer's Research & Therapy.
[11] J. Lingler,et al. Patients’ and Family Members’ Subjective Experiences of a Diagnostic Evaluation of Mild Cognitive Impairment , 2018, Journal of patient experience.
[12] R. Khandker,et al. Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease , 2019, International journal of Alzheimer's disease.
[13] M. Carrillo,et al. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia , 2019, JAMA.
[14] A. Atri. The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. , 2019, The Medical clinics of North America.
[15] P. Sachdev,et al. Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis. , 2019, Journal of Alzheimer's disease : JAD.
[16] Carme Carrion,et al. Cognitive Therapy for Dementia Patients: A Systematic Review , 2018, Dementia and Geriatric Cognitive Disorders.
[17] C. Jack,et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.
[18] Ron Brookmeyer,et al. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States , 2018, Alzheimer's & Dementia.
[19] Ronald C. Petersen,et al. Practice guideline update summary: Mild cognitive impairment , 2018, Neurology.
[20] J. Karlawish,et al. Awareness of Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia Diagnoses Associated With Lower Self-Ratings of Quality of Life in Older Adults , 2017, The journals of gerontology. Series B, Psychological sciences and social sciences.
[21] R. Kane,et al. Societal and Family Lifetime Cost of Dementia: Implications for Policy , 2017, Journal of the American Geriatrics Society.
[22] Amit J. Shah,et al. Correlates of Dementia and Mild Cognitive Impairment in Patients With Atrial Fibrillation: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC‐NCS) , 2017, Journal of the American Heart Association.
[23] J. Karlawish,et al. A Typical Day With Mild Cognitive Impairment. , 2017, American journal of public health.
[24] U. Sambamoorthi,et al. Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States , 2017, Expert review of pharmacoeconomics & outcomes research.
[25] Sterling C. Johnson,et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults , 2015, Alzheimer's & Dementia.
[26] F. Jessen,et al. Elevated HbA1c is associated with increased risk of incident dementia in primary care patients. , 2015, Journal of Alzheimer's disease : JAD.
[27] Z. Khachaturian,et al. Alzheimer's & Dementia: Translational Research & Clinical Interventions , 2015 .
[28] M. Vinciguerra,et al. An association study between epicardial fat thickness and cognitive impairment in the elderly. , 2014, American journal of physiology. Heart and circulatory physiology.
[29] R. Beard,et al. Making sense of nonsense: experiences of mild cognitive impairment. , 2013, Sociology of health & illness.
[30] G. Eslick,et al. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. , 2013, Epidemiologic reviews.
[31] Paco Martorell,et al. Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.
[32] Amy E. Sanders,et al. Age-specific and Sex-specific Prevalence and Incidence of Mild Cognitive Impairment, Dementia, and Alzheimer Dementia in Blacks and Whites: A Report From the Einstein Aging Study , 2012, Alzheimer disease and associated disorders.
[33] E. Sinforiani,et al. Caregiver Burden and Coping in Early-stage Alzheimer Disease , 2012, Alzheimer disease and associated disorders.
[34] N. Meader,et al. Clinical recognition of dementia and cognitive impairment in primary care: a meta‐analysis of physician accuracy , 2011, Acta psychiatrica Scandinavica.
[35] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[36] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[37] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[38] M. Albert,et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[39] N. Bhat. Linking cardiometabolic disorders to sporadic Alzheimer’s disease: a perspective on potential mechanisms and mediators , 2010, Journal of neurochemistry.
[40] M. Dale,et al. Review: Obesity and Alzheimer’s Disease: A Link Between Body Weight and Cognitive Function in Old Age , 2009, American journal of Alzheimer's disease and other dementias.
[41] Z. Khachaturian. Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2008, Alzheimer's & Dementia.
[42] Richard Schulz,et al. Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience. , 2006, The Gerontologist.
[43] A. Ott. Risk of dementia: The Rotterdam Study , 1997 .
[44] Vijaya L. Melnick,et al. Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.
[45] M. Ganguli,et al. Practice guideline update summary: Mild cognitive impairment Report of theGuidelineDevelopment, Dissemination, and Implementation Subcommittee of the American Academy ofNeurology , 2022 .